Using in situ hybridization on whole-mounts and sections of mouse embryos we have visualized the pattern of expression for the Eph receptor ligand ephrin-A5. Non neuronal expression domains include the ectoderm of the branchial arches, the ectoderm and mesenchyme surrounding the dorsal root ganglia, the intervertebral discs, maxillary and mandibulary mesenchymal elements as well as the nasal mesenchyme and ectoderm. Within the developing nervous system, ephrin-A5 expression is very dynamic. Besides the midbrain it is also expressed in the hypothalamus, and the neurohypohysis that we studied here in more detail. Hypothalamus expression of ephrin-A5 demarks distinct nuclei, persists throughout embryonic development, and can be seen also in the adult. q
Results
The receptor tyrosine kinases of the Eph subtype and their ligands have been shown to mediate contact dependent cell interactions. In particular, due to their repulsive activity upon receptor-ligand binding, they have been implicated in axon guidance and the establishment of topographic maps, restriction of cell migration, and establishment of morphological boundaries during embryonic development (reviewed by Drescher, 1997; Holder and Klein, 1999) . Based on sequence homology and binding speci®city the Eph receptors and their ligands, the Ephrins, are divided into two subclasses (A and B) and in general they show a complementary pattern of expression . It has been shown that ephrin-A5 plays a crucial role in establishing the retinotectal topography by repulsing outgrowing axons from temporal retina (Drescher et al., 1995; Feldheim et al., 1998; Frisen et al., 1998) and works in general as a repulsive signal in axon guidance (Winslow et al., 1995; Donoghue et al., 1996; Ohta et al., 1997; Gao et al., 1998) . To date embryonic expression of ephrin-A5 has been extensively reported for the midbrain and forebrain targets of retinal innervation, and additional sites of expression in the hypothalamus, the spinal motoneurons, branchial arches and limbs were suggested Zhang et al., 1996 , Feldheim et al., 1998 . Here we present a more detailed expression analysis covering midgestational stages and focus on ephrin-A5 expression during development of pituitary and hypothalamus.
In whole-mount embryos ephrin-A5 can be detected from E8.5 in the headfolds and from E10.5 in the ectoderm of the brancial arches, and in the facial ectoderm and mesenchyme ( Fig. 1A and data not shown). At E11.5 and later ephrin-A5 transcripts can be detected in two lateral stripes along the backline in the dorsal ectoderm and mesenchyme surrounding the dorsal root ganglia (Fig. 1A and data not shown). Additionally on sagittal sections of E12.5 old embryos transcripts are found in the intervertebral discs and in a proximoventral region of the mandible (Fig. 1C) .
At E12.5 ephrin-A5 is also expressed in the ventral diencephalon the region of the developing hypothalamus and neurohypophysis (Fig. 1C,D) . This expression domain appears much earlier then previously reported and corresponds to a crucial stage in development of the pituitary gland when Rathke's pouch loses its connection to the stomodeum and forms a sac adjacent to the infundibulum. To study this expression domain in more detail we performed an expression analysis using 35 S labeled riboprobes on sagittal sections at different developmental stages. Here, expression can be seen within the neuroepithelium in a gradient with a maximum in the most ventral part of the hypothalamus and decreasing intensity more dorsal (Fig. 2) . This most ventral point is the region where the infundibulum, the anlage of the posterior hypophysis, and the hypothalamus come in contact with the Rathke's pouch, the anlage of the anterior hypophysis (adenohypophysis). Rathke's pouch is not or very weakly expressing ephrin-A5 as well as cartilagous tissue of the stomodeum below ( Fig.   2A±D ). At birth (P0) ephrin-A5 transcripts can be detected throughout the hypothalamus from the preoptic area to the In the caudal hypothalamus can be seen that the medial and lateral mammillary nuclei are strongly positive for ephrin-A5. (E,F) At P6 ephrin-A5 expression is visible in arcuate, dorsal medial, and ventromedial hypothalamic nucleus. In addition, lateral and medial mammillary nuclei as well as lateral supramammillary nucleus show intensive ephrin-A5 expression. (G±K) Shows expression in the adult (P40±P60) hypothalamus throughout its rostro-caudal extension. Here we can detect ephrin-A5 transcripts in the suprachiasmatic nucleus (G), the paraventricular hypothalamic nucleus (H), throughout the entire extension of the arcuate nucleus (I,J), and in the lateral mammillary nuclei (K). AL, anterior lobe; AR, arcuate nucleus; DMH, dorsal medial hypothalamic nucleus; HY, hypothalamus; IL, intermediate lobe; LM, lateral mammillary nucleus; LS, lateral supramammillary nucleus; ME, median eminence; MM, medial mammillary nucleus; PL, posterior lobe; PV, paraventricular hypothalamic nucleus; SC, suprachiasmatic nucleus; VMH, ventromedial hypothalamic nucleus; III, 3rd ventricle. (Fig. 3A and data not shown) . Marked expression is visible in the ventral hypothalamus with highest levels in the arcuate nucleus and the medial and lateral mammillary nuclei (Fig. 3C,D) . Expression in the described territories of hypothalamus and pituitary gland persists throughout development. In juvenile stages expression of ephrin-A5 can mainly be seen in arcuate, dorsal medial, and ventromedial hypothalamic nucleus as well as in medial and lateral mammillary nuclei (Fig. 3E,F) . In the adult hypothalamus we can detect ephrin-A5 transcripts in the suprachiasmatic nucleus (Fig. 3G) , the paraventricular hypothalamic nucleus (Fig. 3H) , throughout the entire rostro-caudal extension of the arcuate nucleus (Fig. 3I,J) , and in the lateral mammillary nuclei (Fig. 3K) . ephrin-A5 can neither be detected in the posterior nor the intermediate lobe of the adult pituitary (data not shown). In conclusion, our results show that ephrin-A5 is expressed in a very dynamic fashion during mouse development. The novel expression domains we present include the nasal mesenchyme and ectoderm, the intervertebtral discs, the ectoderm and mesenchyme surrounding the dorsal root ganglia, mandibulary and maxillary mesenchymal elements as well as distinct structures of the developing and adult hypothalamus and pituitary that is a major site of expression.
Methods
Mouse C3H embryos were dissected in diethylpyrocarbonate (DEPC)-treated PBS and ®xed in cold 4% PFA in PBS. After ®xation embryos were dehydrated and stored in methanol at 2208C before whole-mount in situ hybridization. In situ hybridization on sections was performed on tissue that was dehydrated in isopropanol, embedded in paraf®n, and sectioned at 7±10 mm. Alternatively, fresh frozen and 20 mm sectioned tissue was hybridized. Stage of collected embryos was determined according to Kaufman (1992) . A 0.93 kbp long cDNA fragment of mouse ephrin-A5 representing part of 5 H UTR (543 bp) and coding sequence (385 bp) was subcloned into the EcoRI site of pBluescript II KS1. Sense and antisense probes were synthesized in vitro with T3 and T7 RNA polymerase and labeled with digoxigenin-11-UTP (Boehringer Mannheim) or [ 35 S]UTP (NEN Life Science Products Inc.) according to manufacturers instructions (Boehringer Mannheim). Whole-mount in situ hybridizations were performed with digoxigenin-labeled cRNA probes as described byWilkinson (1992) . As a chromogenic substrate for the color reaction BM Purple AP substrate containing 2 mM levamisole and 0.1% Tween-20 was used. In situ hybridizations on sections were performed according to Dagerlind et al. (1992) with small modi®ca-tions. After developing the exposed ®lm emulsion (Kodak, NTB-2) on sections counterstaining in 0.025% thionin for detailed histological analysis was performed. The sense probe did not show any detectable signal.
